about
Clinical lung xenotransplantation--what donor genetic modifications may be necessary?Immune modulation in xenotransplantationRAGE controls activation and anti-inflammatory signalling of protein CMechanism of the Anticoagulant Activity of Thrombin Mutant W215A/E217ACrystal structures of murine thrombin in complex with the extracellular fragments of murine protease-activated receptors PAR3 and PAR4Structural identification of the pathway of long-range communication in an allosteric enzymeStabilization of the E* Form Turns Thrombin into an AnticoagulantMolecular mapping of the thrombin-heparin cofactor II complexExosite-driven substrate specificity and function in coagulationA 2014 Update on Coagulation Management for Cardiopulmonary Bypass.Zebrafish: a genetic model for hemostasis and thrombosis.Molecular recognition mechanisms of thrombin.Factor V Leiden improves in vivo hemostasis in murine hemophilia models.Structure-based predictive models for allosteric hot spots.A new measure for in vivo thrombin activity in comparison with in vitro thrombin generation potential in patients with hyper- and hypocoagulabilityEndothelial protein C receptor-assisted transport of activated protein C across the mouse blood-brain barrierNMR resonance assignments of thrombin reveal the conformational and dynamic effects of ligation.Genetic background analysis of protein C deficiency demonstrates a recurrent mutation associated with venous thrombosis in Chinese population.Modeling of human factor Va inactivation by activated protein C.The tissue factor requirement in blood coagulation.Mac-1 directly binds to the endothelial protein C-receptor: a link between the protein C anticoagulant pathway and inflammation?Overexpression of the endothelial protein C receptor is detrimental during pneumonia-derived gram-negative sepsis (Melioidosis).Differential gene expression in thrombomodulin (TM; CD141)(+) and TM(-) dendritic cell subsetsAssociation between biomarkers of endothelial injury and hypocoagulability in patients with severe sepsis: a prospective study.Does the genotype predict the phenotype? Evaluations of the hemostatic proteome.Inducing Acute Traumatic Coagulopathy In Vitro: The Effects of Activated Protein C on Healthy Human Whole Blood.Prenatal screening for thrombophilia: the background and the approach.Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases.Emerging role of direct thrombin inhibitors in nonvalvular atrial fibrillation: potential and peril.The anticoagulant protein C pathway.Pathogenic antibodies to coagulation factors. Part II. Fibrinogen, prothrombin, thrombin, factor V, factor XI, factor XII, factor XIII, the protein C system and von Willebrand factor.Meizothrombin is an unexpectedly zymogen-like variant of thrombin.Plasmodium falciparum adhesion domains linked to severe malaria differ in blockade of endothelial protein C receptor.Coagulopathy and the role of recombinant human activated protein C in sepsis and following polytrauma.Role of Na+ and K+ in enzyme function.Inflammation and coagulation in inflammatory bowel disease: The clot thickens.Coagulation and the xenograft endothelium.Emerging role of anticoagulants and fibrinolytics in the treatment of acute respiratory distress syndromeDrotrecogin alpha (activated): the treatment for severe sepsis?The Fragment 1 Region of Prothrombin Facilitates the Favored Binding of Fragment 12 to Zymogen and Enforces Zymogen-like Character in the Proteinase.
P2860
Q26823663-5337C561-A82D-42A0-8646-502E4B24C44AQ26826905-8E28803C-B48D-49D5-B4D8-C521C49A0DF3Q27320852-5B807934-50CF-4272-B06B-82B35F826B22Q27646504-C0A19770-0857-4535-9359-EAFE154EB95EQ27646532-62224CA3-B1A0-4EE3-B47C-246C42A3B46BQ27649783-BA4BA210-65EF-4150-BD92-034D2ED07C1FQ27655637-DF1D7007-3BD7-4E3B-927C-DA7B1FA21051Q28275459-66DDD1D9-C227-46AD-8EFB-246581B66E5DQ28301227-2ADD5BCD-80FB-4262-B0ED-C60458576CFEQ30458252-60FD13C5-B481-456E-BF87-DFC84D6E2D99Q31139050-D6A2C785-3B34-472E-8D87-AC01211F56FDQ33221756-83F54EBB-12F5-40AA-AF88-265F68A883E5Q33229687-0322DC14-2F2C-429F-A764-0864A1A73656Q33509504-C905B059-3E84-40CA-9A50-D0F9CBF36AC7Q33599937-1672AEDA-A612-4787-8C21-4129C012CA2DQ33954036-0B7D23B3-CA70-4140-A5E5-8ADE0C984A11Q34069668-2B191AA3-A59A-443A-8A88-0ED480EACE4CQ34251221-FD824B1E-A656-4893-84ED-07ED5BC005CBQ34274796-75F509F9-BCB8-4F9D-9F20-4325A263BAF1Q34360277-515434E1-3D6D-4D60-B8DA-B22A45967755Q34585829-3B721B08-9F1D-4ED1-B2C1-A679AE3FC8AFQ34855284-85FA8BB2-D1FC-45C0-BC79-9C1A91CA8C7EQ34979529-480BB920-32F4-4203-96E1-03FCA84966E7Q35579255-88BBA4FA-2BE1-4DA1-9123-92E4D0F5CAF7Q35904936-27C75640-ADBF-4BC4-900E-4D3700EE78A1Q35967850-87EEFD6C-1972-4ECD-9FF6-3FB66E9CC9F8Q36030393-333A0986-BBC0-47AB-A6D2-AB0E1BAEB69CQ36044569-9DBC8670-642F-41BA-9A26-B5E9AAC9DD3FQ36094367-07F4F983-CECE-4102-BC72-8A179499B774Q36156027-C706753D-BBC3-4C24-ADC2-5F90EAB58F8AQ36174626-03FC1C4D-E829-4417-BA2A-3C6758F2D114Q36216378-F050975E-5CE8-485A-A27D-F1DB6826059CQ36322445-A130D6A5-639D-411F-83A8-B6C2DE9D809BQ36349735-763F4ED5-1467-4981-832D-7E880D1999CEQ36610450-A4FEF30D-7087-40E2-93C6-FB16EE429456Q36652262-28458D9E-9AAD-4892-A3C7-A4D78CC9072CQ36703877-5645B954-FE47-4116-872F-07C65F65D9ACQ36835719-3DAEE8B1-9310-467C-A4DD-7DF90958F518Q36981698-7F3DCC65-CE72-47E2-B452-04A8994C1A65Q36987640-1780BB19-E324-45BA-8AEC-3341BDE379E6
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
The Protein C Pathway
@en
The Protein C Pathway
@nl
type
label
The Protein C Pathway
@en
The Protein C Pathway
@nl
prefLabel
The Protein C Pathway
@en
The Protein C Pathway
@nl
P1433
P1476
The protein C pathway
@en
P2093
Charles T Esmon
P304
P356
10.1378/CHEST.124.3_SUPPL.26S
P407
P433
P577
2003-09-01T00:00:00Z